Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.25 -0.25 (-7.14%)
As of: Oct 20, 2026 · 3:58 PM EDT

Apimeds Pharmaceuticals US (APUS) Accounts Payables (2023 - 2026)

Updated

Apimeds Pharmaceuticals US (APUS) reported Accounts Payables of $3.22 million for Q2 2026, compared with $119,138 a year earlier.

Analysis

Apimeds Pharmaceuticals US (APUS) Accounts Payables (2023 - 2026) Analysis & Trends

At the end of FY2025, Apimeds Pharmaceuticals US posted Accounts Payables of $918,649, up 55.4% from FY2024.

  • By year, Accounts Payables came in at $591,191 in FY2024 (+986.0%) and $54,438 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 9.22 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 33.30 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 3.83 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 22.89 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 674.00 Mn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 4.58 Bn
10 Apimeds Pharmaceuticals US 5.65 Mn -13.98 Mn - 3.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.22 Mn
Dec 31, 2025 918,649.00
Sep 30, 2025 567,633.00
Jun 30, 2025 119,138.00
Mar 31, 2025 935,203.00
Dec 31, 2024 591,191.00
Dec 31, 2023 54,438.00
API Access

Apimeds Pharmaceuticals US Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=APUS&period=max&api_key=YOUR_API_KEY